Davis Polk has long been the firm of choice for many of the world’s leading blue chip companies and financial institutions.
Our recent transactions include:
Aetna.We advised Aetna on its $77 billion acquisition by CVS Health – named 2018 “Global M&A Deal of the Year” by American Lawyer.
Shire. We advised Shire on its $62 billion acquisition by Takeda Pharmaceutical in the largest cross-border pharmaceutical industry deal.
Syngenta. We advised Syngenta on its $43 billion acquisition by ChemChina – the largest Chinese outbound M&A transaction ever and named “M&A Deal of the Year” at the 2018 IFLR European Awards.
Comcast. We advised Comcast on its $40 billion successful contested acquisition of Sky – Will Pearce was named "Dealmaker of the Year" by The American Lawyer for this representation.
Baker Hughes. We advised Baker Hughes on its $25 billion combination with GE’s oil and gas business – named “M&A Deal of the Year” at the 2018 IFLR Americas Awards.
Reckitt Benckiser. We advised Reckitt Benckiser on its $17.9 billion acquisition of Mead Johnson Nutrition.
IHS Markit.We advised Markit on its $13 billion merger of equals with IHS.
General Electric. We advised GE on the $11.1 billion merger of GE Transportation and Wabtec.
Williams. We advised Williams Companies on its $10.5 billion acquisition of all of the outstanding public common units of Williams Partners in an all stock-for-unit transaction.
Natura. We advised Natura, a global cosmetics group in Brazil, on its pending $3.5 billion acquisition of Avon Products.
Tencent. We advised Tencent on its pending investment in 10% of Universal Music Group’s share capital.
FMC. We advised FMC, an agrichemical company, on the $1.6 billion spinoff of its shares of common stock of Livent, a producer of high-quality finished lithium compounds.